CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Calcimedica Inc - CALC CFD

    4.8609
    6.86%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.3682
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.024874%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.002651%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 0.001
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 5.2188
    Open* 5.1867
    1-Year Change* 314.94%
    Day's Range* 4.8609 - 5.3763
    52 wk Range 4.88-20.30
    Average Volume (10 days) 36.06K
    Average Volume (3 months) 150.00K
    Market Cap 27.59M
    P/E Ratio -100.00K
    Shares Outstanding 5.52M
    Revenue N/A
    EPS -23.21
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date May 8, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Mar 29, 2023 4.8609 -0.3258 -6.28% 5.1867 5.4138 4.8597
    Mar 28, 2023 5.2188 -0.1502 -2.80% 5.3690 5.8530 4.9029
    Mar 27, 2023 5.5461 0.1553 2.88% 5.3908 6.0853 5.3883
    Mar 24, 2023 5.5507 0.0832 1.52% 5.4675 5.7853 5.4675
    Mar 23, 2023 5.4929 0.1525 2.86% 5.3404 5.8023 5.3404
    Mar 22, 2023 5.5768 0.2301 4.30% 5.3467 6.5507 5.0805
    Mar 21, 2023 6.0468 1.2311 25.56% 4.8157 6.1436 4.7284
    Mar 20, 2023 5.3451 -0.6469 -10.80% 5.9920 5.9920 5.0602
    Mar 17, 2023 0.4280 -0.0478 -10.05% 0.4758 0.4763 0.4273
    Mar 16, 2023 0.4761 -0.0195 -3.93% 0.4956 0.4958 0.4580
    Mar 15, 2023 0.4937 0.0277 5.94% 0.4660 0.4969 0.4660
    Mar 14, 2023 0.4762 -0.0145 -2.95% 0.4907 0.4957 0.4737
    Mar 13, 2023 0.4960 -0.0093 -1.84% 0.5053 0.5151 0.4859
    Mar 10, 2023 0.5041 0.0008 0.16% 0.5033 0.5120 0.4857
    Mar 9, 2023 0.5346 -0.0034 -0.63% 0.5380 0.5637 0.5164
    Mar 8, 2023 0.5638 0.0408 7.80% 0.5230 0.5647 0.5230
    Mar 7, 2023 0.5637 0.0395 7.54% 0.5242 0.5823 0.5242
    Mar 6, 2023 0.5556 -0.0273 -4.68% 0.5829 0.5829 0.5537
    Mar 3, 2023 0.5476 0.0429 8.50% 0.5047 0.5588 0.5047
    Mar 2, 2023 0.5345 0.0292 5.78% 0.5053 0.5347 0.5053

    Calcimedica Inc Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0 0 0 0 0
    Total Operating Expense 36.18 35.947 29.832 37.502 28.57
    Selling/General/Admin. Expenses, Total 19.104 17.044 8.87 6.922 5.599
    Research & Development 14.113 18.903 20.962 30.58 22.971
    Operating Income -36.18 -35.947 -29.832 -37.502 -28.57
    Interest Income (Expense), Net Non-Operating 0.575 0.126 0.143 0.393 0.192
    Other, Net 0 2.158 0.072 0
    Net Income Before Taxes -35.605 -35.821 -27.531 -37.037 -28.378
    Net Income After Taxes -35.605 -35.821 -27.531 -37.037 -28.378
    Net Income Before Extra. Items -35.605 -35.821 -27.531 -37.037 -28.378
    Net Income -35.605 -35.821 -27.531 -37.037 -28.378
    Total Adjustments to Net Income 0 -7.189 -7.055 -4.317
    Income Available to Common Excl. Extra. Items -35.605 -35.821 -34.72 -44.092 -32.695
    Income Available to Common Incl. Extra. Items -35.605 -35.821 -34.72 -44.092 -32.695
    Diluted Net Income -35.605 -35.821 -34.72 -44.092 -32.695
    Diluted Weighted Average Shares 1.53498 1.51427 1.50317 1.36829 1.36829
    Diluted EPS Excluding Extraordinary Items -23.1957 -23.6557 -23.0978 -32.2243 -23.8949
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -21.2654 -23.6557 -23.0978 -32.2243 -23.8949
    Unusual Expense (Income) 2.963
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Total revenue 0 0 0 0 0
    Total Operating Expense 7.712 9.983 8.301 10.184 8.701
    Selling/General/Admin. Expenses, Total 6.435 4.299 4.243 4.127 4.433
    Research & Development 0.749 3.249 4.058 6.057 4.268
    Operating Income -7.712 -9.983 -8.301 -10.184 -8.701
    Interest Income (Expense), Net Non-Operating 0.309 0.171 0.06 0.035 0.026
    Other, Net 0
    Net Income Before Taxes -7.403 -9.812 -8.241 -10.149 -8.675
    Net Income After Taxes -7.403 -9.812 -8.241 -10.149 -8.675
    Net Income Before Extra. Items -7.403 -9.812 -8.241 -10.149 -8.675
    Net Income -7.403 -9.812 -8.241 -10.149 -8.675
    Total Adjustments to Net Income 0
    Income Available to Common Excl. Extra. Items -7.403 -9.812 -8.241 -10.149 -8.675
    Income Available to Common Incl. Extra. Items -7.403 -9.812 -8.241 -10.149 -8.675
    Diluted Net Income -7.403 -9.812 -8.241 -10.149 -8.675
    Diluted Weighted Average Shares 1.54484 1.53836 1.53099 1.52559 1.52415
    Diluted EPS Excluding Extraordinary Items -4.79207 -6.37822 -5.3828 -6.65253 -5.69171
    Dividends per Share - Common Stock Primary Issue 0 0 0
    Diluted Normalized EPS -4.45029 -4.79536 -5.3828 -6.65253 -5.69171
    Unusual Expense (Income) 0.528 2.435
    • Annual
    • Quarterly
    2021 2020 2019 2018
    Total Current Assets 67.078 99.24 36.271 13.445
    Cash and Short Term Investments 63.67 95.033 35.956 12.834
    Cash & Equivalents 13.364 33.418 15.87 12.834
    Short Term Investments 50.306 61.615 20.086 0
    Prepaid Expenses 2.034 4.207 0.315 0.611
    Total Assets 69.088 101.794 40.66 17.813
    Property/Plant/Equipment, Total - Net 1.981 1.946 1.975 1.515
    Property/Plant/Equipment, Total - Gross 3.634 3.08 2.714 1.958
    Accumulated Depreciation, Total -1.653 -1.134 -0.739 -0.443
    Other Long Term Assets, Total 0.029 0.608 2.414 2.853
    Total Current Liabilities 4.057 6.997 12.251 5.794
    Accounts Payable 0.527 2.513 4.636 2.523
    Accrued Expenses 2.582 3.658 4.377 2.924
    Notes Payable/Short Term Debt 0 0 0 0
    Other Current Liabilities, Total 0.948 0.826 3.238 0.347
    Total Liabilities 4.065 7.008 12.251 5.794
    Total Long Term Debt 0 0 0 0
    Total Equity 65.023 94.786 28.409 12.019
    Preferred Stock - Non Redeemable, Net 0 0 131.363 78.811
    Common Stock 0.002 0.002 0 0
    Additional Paid-In Capital 234.225 228.155 2.879 2.007
    Retained Earnings (Accumulated Deficit) -169.188 -133.367 -105.836 -68.799
    Unrealized Gain (Loss) -0.016 -0.004 0.003 0
    Total Liabilities & Shareholders’ Equity 69.088 101.794 40.66 17.813
    Total Common Shares Outstanding 21.3578 20.9793 19.1556 19.1556
    Other Liabilities, Total 0.008 0.011
    Total Preferred Shares Outstanding 0
    Total Receivables, Net 0.021
    Other Current Assets, Total 1.353
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 58.222 67.078 74.496 76.051 88.821
    Cash and Short Term Investments 55.28 63.67 72.554 73.586 85.688
    Cash & Equivalents 8.36 13.364 11.452 7.864 10.589
    Short Term Investments 46.92 50.306 61.102 65.722 75.099
    Prepaid Expenses 2.942 3.408 1.942 2.465 3.133
    Total Assets 60.586 69.088 76.638 82.821 90.852
    Property/Plant/Equipment, Total - Net 2.335 1.981 2.113 2.006 2.002
    Other Long Term Assets, Total 0.029 0.029 0.029 0.136 0.029
    Total Current Liabilities 4.228 4.057 4.49 4.141 6.278
    Accounts Payable 0.541 0.527 2.066 2.101 1.956
    Accrued Expenses 2.216 2.582 1.729 1.543 3.378
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 1.471 0.948 0.695 0.497 0.944
    Total Liabilities 4.33 4.065 4.502 4.154 6.29
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 0.102 0.008 0.012 0.013 0.012
    Total Equity 56.256 65.023 72.136 78.667 84.562
    Common Stock 0.002 0.002 0.002 0.002 0.002
    Additional Paid-In Capital 235.767 234.225 232.641 231.183 229.376
    Retained Earnings (Accumulated Deficit) -179.337 -169.188 -160.513 -152.524 -144.816
    Unrealized Gain (Loss) -0.176 -0.016 0.006 0.006 0
    Total Liabilities & Shareholders’ Equity 60.586 69.088 76.638 82.821 90.852
    Total Common Shares Outstanding 21.3578 21.3578 21.3166 21.2847 21.0559
    Long Term Investments 4.628
    Preferred Stock - Non Redeemable, Net 0 0
    • Annual
    • Quarterly
    2021 2020 2019 2018
    Net income/Starting Line -35.821 -27.531 -37.037 -28.378
    Cash From Operating Activities -31.5 -32.064 -31.215 -28.216
    Cash From Operating Activities 0.519 0.395 0.303 0.175
    Non-Cash Items 5.433 -0.369 0.598 0.366
    Changes in Working Capital -1.631 -4.559 4.921 -0.379
    Cash From Investing Activities 10.751 -42.56 -20.62 -1.461
    Capital Expenditures -0.488 -1.023 -0.605 -1.461
    Other Investing Cash Flow Items, Total 11.239 -41.537 -20.015 0
    Cash From Financing Activities 0.695 92.172 54.871 42.019
    Financing Cash Flow Items 0 -4.16 -0.045 0
    Issuance (Retirement) of Stock, Net 0.695 96.332 54.916 42.019
    Net Change in Cash -20.054 17.548 3.036 12.342
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -10.149 -35.821 -27.146 -19.157 -11.449
    Cash From Operating Activities -6.524 -31.5 -22.545 -17.045 -9.264
    Cash From Operating Activities 0.122 0.519 0.383 0.247 0.118
    Non-Cash Items 3.81 5.433 3.946 2.508 1.169
    Changes in Working Capital -0.307 -1.631 0.272 -0.643 0.898
    Cash From Investing Activities 1.52 10.751 -0.035 -9.096 -13.657
    Capital Expenditures 0 -0.488 -0.484 -0.304 -0.136
    Other Investing Cash Flow Items, Total 1.52 11.239 0.449 -8.792 -13.521
    Cash From Financing Activities 0 0.695 0.614 0.587 0.092
    Financing Cash Flow Items 0 0 0 0
    Issuance (Retirement) of Stock, Net 0 0.695 0.614 0.587 0.092
    Net Change in Cash -5.004 -20.054 -21.966 -25.554 -22.829
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Deerfield Management Company, L.P. Hedge Fund 6.8373 377265 0 2022-12-31 MED
    OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 5.3895 297380 -2 2023-03-24 LOW
    Wilson (Robert N) Individual Investor 11.5614 181655 181655 2023-03-20
    BML Capital Management LLC Investment Advisor 1.6 88282 0 2022-12-31 MED
    Breuil (Robert S) Individual Investor 0.6207 34246 29340 2023-03-23 HIGH
    Zamiri (Parisa) Individual Investor 0.6002 33117 30424 2023-03-23 HIGH
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.5436 29995 13 2022-12-31 LOW
    CVF 2018, LLC Corporation 0.3531 19485 -56817 2021-12-31
    First Manhattan Co. LLC Investment Advisor 0.3512 19381 -1476 2022-12-31 LOW
    Stauderman (Kenneth A. Ph.D.) Individual Investor 0.7602 11944 11944 2023-03-20
    Renaissance Technologies LLC Hedge Fund 0.2019 11143 -3178 2022-12-31 HIGH
    Guerard (Frederic) Individual Investor 0.0388 8409 1218 2022-12-01 LOW
    BNY Mellon Asset Management Investment Advisor 0.1297 7159 -54 2022-12-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.0857 4730 -12 2022-12-31 LOW
    Johnson & Johnson Innovation-JJDC, Inc. Venture Capital 0.0641 3539 0 2022-12-31 LOW
    Susquehanna International Group, LLP Investment Advisor 0.0581 3204 -1313 2022-12-31 MED
    Hatteras Venture Partners Venture Capital 0.0557 3076 -111584 2021-12-31 LOW
    Bridgeway Capital Management, LLC Investment Advisor 0.0542 2993 -1578 2022-12-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.0454 2505 0 2022-12-31 LOW
    Bjerkholt (Eric H) Individual Investor 0.0259 1429 1429 2023-03-23 LOW

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    500K+

    Trader

    92K+

    Klien aktif per bulan

    $53M+

    Volume investasi per bulan

    $30M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Bio Therapeutic Drugs

    505 Coast Boulevard South
    Suite 307
    LA JOLLA
    CALIFORNIA 92037
    US

    Income Statement

    • Annual
    • Quarterly

    People also watch

    Oil - Crude

    74.03 Price
    -0.120% 1D Chg, %
    Biaya inap posisi Long -0.0170%
    Biaya inap posisi short -0.0049%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    Natural Gas

    2.13 Price
    +0.280% 1D Chg, %
    Biaya inap posisi Long -0.4441%
    Biaya inap posisi short 0.4222%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.005

    US100

    12,974.50 Price
    -0.020% 1D Chg, %
    Biaya inap posisi Long -0.0249%
    Biaya inap posisi short 0.0027%
    Waktu biaya inap 21:00 (UTC)
    Spread 1.8

    Gold

    1,975.68 Price
    -0.010% 1D Chg, %
    Biaya inap posisi Long -0.0180%
    Biaya inap posisi short 0.0098%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda